Beta-amyloid is a small protein that naturally occurs in the brain. However, in Alzheimer's disease, beta-amyloid accumulates in abnormal clumps or plaques that disrupt the normal function of brain cells.
The simulations, conducted by researchers at the University of California, Berkeley, showed that beta-amyloid can bind to and damage the lipids that make up the cell membrane of neural cells. This damage causes the membrane to become leaky, allowing ions and other molecules to enter the cell that should not be there.
The influx of ions into the cell disrupts the cell's normal function and ultimately leads to cell death.
The simulations also showed that the damage caused by beta-amyloid was more pronounced in neural cells that were already stressed or damaged. This suggests that beta-amyloid may be more likely to kill neural cells that are already struggling to survive.
The findings of this study provide a better understanding of how beta-amyloid may contribute to the neurodegeneration seen in Alzheimer's disease. They also suggest that targeting beta-amyloid and preventing it from binding to and damaging the cell membrane of neural cells could be a potential therapeutic strategy for treating Alzheimer's disease.